Randomized phase III trial of bendamustine/prednisone versus melphalane/prednisone in the primary treatment of multiple myeloma.

被引：0

作者：

Poenisch, W ^{[1
]}

Mitrou, PS ^{[1
]}

Merkle, KH ^{[1
]}

Herold, M ^{[1
]}

Assmann, M ^{[1
]}

Wilhelm, G ^{[1
]}

Dachselt, K ^{[1
]}

Richter, P ^{[1
]}

Schirmer, V ^{[1
]}

Schulze, M ^{[1
]}

Subert, R ^{[1
]}

Harksel, B ^{[1
]}

Grobe, N ^{[1
]}

Pilkahn, R ^{[1
]}

Stelzer, E ^{[1
]}

Schulze, A ^{[1
]}

Bittrich, A ^{[1
]}

Pasold, R ^{[1
]}

Hoffmann, FA ^{[1
]}

Mittag, T ^{[1
]}

Helbig, W ^{[1
]}

Niederwieser, D ^{[1
]}

机构：

[1] Univ Leipzig, Div Hematol & Oncol, OSHO, Leipzig, Germany

来源：

BLOOD | 2001年 / 98卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3529

引用

页码：850A / 850A

页数：1

共 50 条

[1] A randomized multicenter study of bendamustine/prednisone versus melphalane/prednisone in the primary treatment of multiple myeloma.
Pönisch, W
Mitrou, PS
Merkle, KM
Rieth, A
Herold, M
Schulze, A
Bittrich, A
Assmann, M
Schirmer, V
Wilhelm, G
Dachselt, K
Richter, P
Subert, R
Friedrich, T
Helbig, W
Niederwieser, D
[J]. BLOOD, 1999, 94 (10) : 123A - 123A
[2] Bendamustine/prednisone versus melphalane/prednisone in the primary treatment of multiple myeloma: An updated analysis of the 94BP01 protocol.
Poenisch, W
Mitrou, PS
Merkle, KH
Herold, M
Assmann, M
Wilhelm, G
Dachselt, K
Richter, P
Schirmer, V
Schulze, M
Subert, R
Harksel, B
Grobe, N
Pillkahn, R
Stelzer, E
Schulze, A
Pasold, R
Hoffmann, FA
Mittag, T
Helbig, W
Niederwieser, D
[J]. BLOOD, 2000, 96 (11) : 759A - 759A
[3] A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma
Goldsmith, Scott R.
Slade, Michael J.
Fiala, Mark
Harding, Melinda
Crees, Zachary D.
Schroeder, Mark A.
Stockerl-Goldstein, Keith
Vij, Ravi
[J]. ANNALS OF HEMATOLOGY, 2024,
[4] Bendamustine in combination with thalidomide and prednisone in patients with refractory or relapsed multiple myeloma. preliminary results of a phase I clinical trial
Pönisch, W
Rozanski, M
Leiblein, S
Goldschmidt, H
Wegner, A
Niederwieser, D
[J]. ANNALS OF ONCOLOGY, 2005, 16 : 208 - 208
[5] A RANDOMIZED TRIAL OF MELPHALAN AND PREDNISONE VERSUS MELPHALAN, PREDNISONE, CYCLOPHOSPHAMIDE, MECCNU, AND VINCRISTINE IN UNTREATED MULTIPLE-MYELOMA
PAVLOVSKY, S
SASLAVSKY, J
PINTO, MT
PALMER, L
CURUCHET, M
LEIN, JM
GARAY, G
DRAGOSKY, M
QUIROGAMICHEO, E
HUBERMAN, AB
PIZZOLATTO, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (07) : 836 - 840
[6] Bendamustine and prednisone in combination with bortezomib in the treatment of patients with advanced multiple myeloma
Poenisch, W.
Bourgeois, M.
Wang, S.
Jaekel, N.
Heyn, S.
Braunert, L.
Rohrberg, R.
Hurtz, H.
Hoffmann, F.
Schwarzer, A.
Becker, C.
Al Ali, H.
Niederwieser, D.
[J]. ANNALS OF ONCOLOGY, 2008, 19 : 171 - 171
[7] Oral melphalan, prednisone and thalidomide for multiple myeloma.
Palumbo, A
Bringhen, S
Musto, P
Caravita, T
Capozzi, R
Callea, V
Cangialosi, C
Montanaro, M
Catalano, L
Grasso, M
Petti, MC
Merla, M
Falchi, L
Omedè, P
Ceccarelli, M
Ambrosini, MT
Avonto, I
Gay, F
Falco, P
Boccadoro, M
[J]. BLOOD, 2005, 106 (11) : 230A - 230A
[8] Bortezomib in combination with bendamustine and prednisone in the treatment of patients with refractory/relapsed multiple myeloma
Poenisch, W.
Bourgeois, M.
Wang, S. Y.
Heyn, S.
Jaekel, N.
Al Ali, H.
Niederwieser, D.
[J]. ONKOLOGIE, 2008, 31 : 136 - 136
[9] Bendamustine and prednisone in combination with Bortezomib in the treatment of patients with relapsed/refractory multiple myeloma
Poenisch, W.
Bourgeois, M.
Heyn, S.
Wagner, I
Jaekel, N.
Rohrberg, R.
Hurtz, H. -J.
Schmalfeld, M.
Assmann, M.
Edelmann, T.
Mohren, M.
Hoffmann, F. A.
Schwarzer, A.
Hensel, G.
Loeschke, K.
Becker, C.
Krahl, R.
Al-Ali, H. K.
Niederwieser, D.
[J]. ONKOLOGIE, 2012, 35 : 144 - 144
[10] Randomized phase III trial of busulfan plus melphalan versus melphalan alone for multiple myeloma.
Qazilbash, Muzaffar H.
Thall, Peter F.
Fox, Patricia S.
Kebriaei, Partow
Bashir, Qaiser
Shah, Nina
Andersson, Borje
Nieto, Yago
Valdez, Ben
Parmar, Simrit
Dinh, Yvonne
Hosing, Chitra
Popat, Uday R.
Shah, Jatin J.
Orlowski, Robert Z.
Champlin, Richard E.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

← 1 2 3 4 5 →